ICU Medical (ICUI) vs Teleflex (TFX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Teleflex (TFX) has outperformed ICU Medical (ICUI) over the past year, gaining 46.6% versus a gain of 21.2%. Over five years, ICUI leads with a -25.9% price change compared with -47.0% for TFX. Teleflex is the larger company by market cap ($6.41 billion vs $4.31 billion), about 1.5 times the size.
On valuation, Teleflex trades at a lower forward P/E (14.8x vs 17.8x for ICU Medical). Teleflex pays a dividend yielding 0.84%, while ICU Medical does not currently pay one. ICU Medical converts more of its revenue into profit, with a net margin of 0.0% versus -45.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICUI | TFX |
|---|---|---|
| Share price | $172.52 | $161.58 |
| Market cap | $4.31B | $6.41B |
| 1-day change | -1.84% | -1.11% |
| YTD return | +20.92% | +32.40% |
| 1-year return | +21.20% | +46.58% |
| 5-year return | -25.87% | -47.05% |
| P/E ratio (TTM) | 72.18 | 79.60 |
| Forward P/E | 17.83 | 14.77 |
| EPS (TTM) | $2.39 | $2.03 |
| Dividend yield | 0.00% | 0.84% |
| Annual dividend | $0.00 | $1.36 |
| Revenue (latest FY) | $2.23B | $1.99B |
| Revenue growth (YoY) | -6.33% | +17.25% |
| Net income (latest FY) | $732.00K | $-905.64M |
| Gross margin | 36.84% | 56.24% |
| Operating margin | 1.92% | 5.94% |
| Net margin | 0.03% | -45.45% |
| 52-week high | $192.85 | $166.75 |
| 52-week low | $113.37 | $100.18 |
| Distance from 52-week high | -10.54% | -3.10% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +12.60% | +4.03% |
| Average volume | 253.20K | 790.19K |
| Shares outstanding | 25.01M | 39.66M |
| Employees | 13,000 | 15,500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TFX has outperformed ICUI by 25.4 percentage points over the past year.
- ICU Medical is more profitable, keeping 0.0 cents of every revenue dollar as net income versus -45.4 cents for Teleflex.
- Teleflex grew revenue faster in its latest fiscal year (+17.25% vs -6.33%).
About ICU Medical
ICUI stock →ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products.
Health Care · Medical/Dental Instruments · 13,000 employees
About Teleflex
TFX stock →Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand.
Health Care · Medical/Dental Instruments · 15,500 employees
ICUI vs TFX FAQ
Which is bigger, ICU Medical or Teleflex?
Teleflex (TFX) is larger, with a market capitalization of $6.41B compared with $4.31B for ICU Medical (ICUI).
Which stock has performed better over the past year, ICUI or TFX?
TFX returned +46.58% over the past 12 months, compared with +21.20% for ICUI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ICUI or TFX?
ICUI has the lower trailing P/E at 72.2, versus 79.6 for TFX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, ICU Medical or Teleflex?
Teleflex pays a dividend yielding 0.84%, while ICU Medical does not currently pay a regular dividend.
Are ICU Medical and Teleflex in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.